Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (441-450 of 495) with videos related to

Pageof 50
Sort By:
BMC Cancer|July 3, 2024
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumorsSimon Kind, Carolina Palacios Castillo, Ria Schlichter, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Cancer Research|January 8, 2011
Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapiesDana D Hu-Lowe, Enhong Chen, Lianglin Zhang, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 2026
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor typesFlorian Viehweger, Paul Wirth, Natalia Gorbokon, et al.
BMC Cancer|December 6, 2018
Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphomaWenchao Li, Niclas C Blessin, Ronald Simon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 29, 2022
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligenceDavid Dum, Tjark L C Henke, Tim Mandelkow, et al.
Oncology Letters|October 16, 2019
Upregulation of SPDEF is associated with poor prognosis in prostate cancerJan Meiners, Katharina Schulz, Katharina Möller, et al.
Pageof 50

Showing results (441-450 of 495) with videos related to

Sort By:
Pageof 50
BMC Cancer|July 3, 2024
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumorsSimon Kind, Carolina Palacios Castillo, Ria Schlichter, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Cancer Research|January 8, 2011
Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapiesDana D Hu-Lowe, Enhong Chen, Lianglin Zhang, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 2026
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor typesFlorian Viehweger, Paul Wirth, Natalia Gorbokon, et al.
BMC Cancer|December 6, 2018
Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphomaWenchao Li, Niclas C Blessin, Ronald Simon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 29, 2022
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligenceDavid Dum, Tjark L C Henke, Tim Mandelkow, et al.
Oncology Letters|October 16, 2019
Upregulation of SPDEF is associated with poor prognosis in prostate cancerJan Meiners, Katharina Schulz, Katharina Möller, et al.
Pageof 50